Sponsors

Bruker Microbiology & Diagnostics

Bruker’s market-leading MALDI Biotyper (MBT) is the globally recognised solution for routine microbial identification.

The company is continuously adding workflows based on the MBT, including MBT Sepsityper for direct identification from positive blood culture, and MBT STAR-BL assays for resistance testing.          

Bruker also market IR Biotyper for strain typing targeting hygiene management, and MICRONAUT for antimicrobial susceptibility testing of bacteria and yeasts.

               Bruker’s molecular testing portfolio comprises assays for virology, mycobacteria and TB testing among other PCR assays and systems. Your SARS-CoV-2 diagnostic workflow can be simplified by automated extraction using the GenoXtract fleXT. The renowned FluoroCycler XT, with simple, intuitive software, is easy to use and generates reliable and easy-to-interpret results for assays such as Bruker’s FluoroType SARS-CoV-2 product line.

Latest Issues

Medica

Messe Dusseldorf
11-14 November, 2024

POCT-for-Scot: Bringing the future to you

SEC Arena, Glasgow
14 November, 2024

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024

11th Digital Pathology & AI Congress: Europe

Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024